TimeStamp

Company Overview

Snapshot

Founded in April 2017 by Amir Elhasid and Ian Solomon, TimeStamp operates with 1–10 employees. The company ceased operations in July 2025, marking a significant change in its trajectory.

Business overview

TimeStamp develops a solution for integrating real-world medication adherence data into healthcare systems without requiring direct patient engagement. The company's core technology involves proprietary Smart Stickers attached to common drugs, which utilize AI-powered algorithms to detect when and how specific drugs were used. This technology is applicable to various medications, including inhalers, eye-drop bottles, transdermals, injectors, and pill packages. The collected data is uploaded to the TimeStamp cloud, facilitating personalized patient care for healthcare systems. TimeStamp's power management solution ensures the Smart Stickers remain functional even after extended periods on the shelf, serving the digital healthcare and patient remote monitoring sectors.

Company Intelligence Q&A

What is the current operational status of TimeStamp?

TimeStamp ceased to operate in July 2025.

When was TimeStamp founded and by whom?

TimeStamp was founded in April 2017 by co-founders Amir Elhasid and Ian Solomon.

What is TimeStamp's primary technology?

TimeStamp's primary technology involves proprietary Smart Stickers that attach to medications and use AI-powered algorithms to track drug usage, along with a cloud-based adherence data system.

Which corporate accelerator program did TimeStamp graduate from?

TimeStamp graduated from the BeyondBio SCALE Corporate Accelerator program in May 2020, completing the program in November 2020.

What markets does TimeStamp's technology serve?

TimeStamp's technology serves healthcare systems, pharmaceutical companies, and insurance companies in the digital healthcare and patient remote monitoring sectors, with a focus on markets in Europe and North America.